Disruptive Acquisition Corp I (DISA) 10-K 17 Apr 23 2022 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Apr. 17, 2023	Jun. 30, 2022
Entity Listings [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Document Transition Report	false
Entity File Number	001-40279
Entity Registrant Name	DISRUPTIVE ACQUISITION CORPORATION I
Entity Central Index Key	0001838831
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	11501 Rock Rose Avenue, Suite 200
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78758
City Area Code	424
Local Phone Number	205-6858
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	true
Entity Public Float			$ 269,225,000
Auditor Firm ID	688
Auditor Name	Marcum LLP
Auditor Location	New York, NY
Class A Ordinary Shares [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	DISA
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		1,709,100
Redeemable Warrants [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	DISAW
Security Exchange Name	NASDAQ
Units [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Trading Symbol	DISAU
Security Exchange Name	NASDAQ
Class B Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		6,875,000

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 28,039	$ 213,495
Prepaid expenses	90,445	406,185
Total current assets	118,484	619,680
Prepaid expenses - non-current	0	90,445
Marketable securities held in trust account	278,984,824	275,018,013
Total assets	279,103,308	275,728,138
Current liabilities:
Accounts payable and accrued expenses	1,460,388	1,088,421
Due to related party	54,241	131,634
Promissory note - related party	0	77,000
Total current liabilities	1,514,629	1,297,055
Warrant liabilities	177,421	11,345,066
Promissory Note Payable to Related Party, Noncurrent	750,000	0
Deferred underwriting discount	9,625,000	9,625,000
Total liabilities	12,067,050	22,267,121
Commitments and contingencies (See Note 6)
Class A ordinary shares subject to possible redemption, 27,500,000 shares at redemption value of $10.14 and $10.00 at December 31, 2022 and 2021, respectively	278,984,823	275,000,000
Shareholders' deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2022 and 2021	0	0
Additional paid-in capital	0	0
Accumulated deficit	(11,949,253)	(21,539,671)
Total shareholders' deficit	(11,948,565)	(21,538,983)
Total liabilities, redeemable ordinary shares and shareholders' deficit	279,103,308	275,728,138
Class A Ordinary Shares [Member]
Shareholders' deficit:
Ordinary shares	0	0
Class B Ordinary Shares [Member]
Shareholders' deficit:
Ordinary shares	$ 688	$ 688

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Liabilities and Shareholders' Deficit
Ordinary shares subject to possible redemption (in shares)	27,500,000	27,500,000
Shareholders' equity:
Preference shares, par value (in dollars per share)	$ 0.0001
Preference shares, shares authorized (in shares)	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Class A Ordinary Shares [Member]
Liabilities and Shareholders' Deficit
Ordinary shares subject to possible redemption (in shares)	27,500,000	27,500,000
Redemption value of shares subject to possible redemption (in dollars per share)	$ 10.14	$ 10
Shareholders' equity:
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, shares issued (in shares)	0	0
Ordinary shares, shares outstanding (in shares)	0	0
Class B Ordinary Shares [Member]
Shareholders' equity:
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, shares issued (in shares)	6,875,000	6,875,000
Ordinary shares, shares outstanding (in shares)	6,875,000	6,875,000

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Loss from Operations
Formation and operating costs	$ 1,559,215	$ 2,011,214
Loss from operations	(1,559,215)	(2,011,214)
Other income:
Dividend earned on trust account	3,966,811	18,013
Change in fair value of warrant liabilities	11,167,645	7,460,809
Offering expenses related to warrant issuance	0	(634,367)
Total other income, net	15,134,456	6,844,455
Net income	$ 13,575,241	$ 4,833,241
Class A Ordinary Shares Subject to Possible Redemption [Member]
Other income:
Weighted average shares outstanding, basic (in shares)	27,500,000	20,897,260
Basic net income per share (in dollars per share)	$ 0.39	$ 0.17
Weighted average shares outstanding, diluted (in shares)	27,500,000	20,897,260
Diluted net income per share (in dollars per share)	$ 0.39	$ 0.17
Non-redeemable Ordinary Shares [Member]
Other income:
Weighted average shares outstanding, basic (in shares)	6,875,000	6,981,164
Basic net income per share (in dollars per share)	$ 0.39	$ 0.17
Weighted average shares outstanding, diluted (in shares)	6,875,000	6,981,164
Diluted net income per share (in dollars per share)	$ 0.39	$ 0.17

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Ordinary Shares [Member] Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2020	$ 719	$ 24,281	$ (12,845)	$ 12,155
Beginning balance (in shares) at Dec. 31, 2020	7,187,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Private placement warrants	$ 0	796,950	0	796,950
Forfeiture of founder shares pursuant to expiration of over-allotment option	$ (31)	31	0	0
Forfeiture of founder shares pursuant to expiration of over-allotment option (in shares)	(312,500)
Initial value of over-allotment private warrant liabilities	$ 0	(441,302)	0	(441,302)
Remeasurement of adjusted value of Class A Ordinary Shares to redemption value		(379,960)	(26,360,067)	(26,740,027)
Net income	0	0	4,833,241	4,833,241
Ending balance at Dec. 31, 2021	$ 688	0	(21,539,671)	(21,538,983)
Ending balance (in shares) at Dec. 31, 2021	6,875,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Remeasurement of adjusted value of Class A Ordinary Shares to redemption value		0	(3,984,823)	(3,984,823)
Net income	$ 0	0	13,575,241	13,575,241
Ending balance at Dec. 31, 2022	$ 688	$ 0	$ (11,949,253)	$ (11,948,565)
Ending balance (in shares) at Dec. 31, 2022	6,875,000

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 13,575,241	$ 4,833,241
Adjustments to reconcile net income to cash provided by operating activities:
Formation costs paid by Sponsor	0	77,000
Dividend earned on trust account	(3,966,811)	(18,013)
Change in fair value of warrant liability	(11,167,645)	(7,460,809)
Offering costs allocated to warrants	0	634,367
Changes in current assets and current liabilities:
Prepaid assets	406,185	(496,630)
Accounts payable and accrued expenses	371,967	1,088,421
Due to related party	0	131,634
Net cash used in operating activities	(781,063)	(1,210,789)
Cash flows from investing activities:
Investment of cash into trust account	0	(275,000,000)
Net cash used in investing activities	0	(275,000,000)
Cash flows from financing activities:
Proceeds from initial public offering, net of underwriters' discount	0	245,000,000
Proceeds from sale of option units to underwriters	0	25,000,000
Proceeds from issuance of private placement warrants	0	7,000,000
Proceeds from issuance of promissory note	673,000	0
Repayment of debt to related party	(77,393)	0
Payments of offering costs	0	(575,716)
Net cash provided by financing activities	595,607	276,424,284
Net change in cash	(185,456)	213,495
Cash - Beginning	213,495	0
Cash - Ending	28,039	213,495
Supplemental disclosure of non-cash financing activities:
Initial value of Class A Ordinary Shares subject to possible redemption	0	275,000,000
Initial value of warrant liabilities	0	18,805,875
Deferred underwriting discount payable charged to additional paid-in capital	0	9,625,000
Remeasurement of adjusted value of Class A ordinary shares to redemption value	$ 3,984,823	$ 0

Organization and Business Opera

Organization and Business Operations	12 Months Ended
	Dec. 31, 2022
Organization, Business Operations and Going Concern [Abstract]
Organization, Business Operations and Going Concern	Note 1 — Organization and Business Operations Organization and General Disruptive Acquisition Corporation I (the “ Company Business Combination As of December 31, 2022, the Company had not yet commenced any operations. All activity for the year ended December 31, 2022, relates to the Company’s formation and its initial public offering (the “ Initial Public Offering Financing The registration statement for the Company’s Initial Public Offering was declared effective on March 23, 2021 (the “ Effective Date Units Class A Ordinary Shares one-third Public Warrants Substantially concurrently with the closing of the Initial Public Offering, the Company completed the private sale (the “ Private Placement Private Placement Warrants Warrants Sponsor In connection with the Initial Public Offering, the underwriters were granted a 45-day option from the date of the prospectus (the “ Over-Allotment Option Option Units Trust Account Following the closing of the Initial Public Offering on March 26, 2021, an amount of $250,000,000 from the net proceeds of the sale of the Units in the Initial Public Offering has been placed in a trust account (the “ Trust Account Investment Company Act On February 14, 2023, the Company held the Extraordinary Meeting. At the Extraordinary Meeting, the Company’s shareholders approved, among other things, an amendment to the Company’s amended and restated memorandum and articles of association to extend the date that the Company has to consummate an initial Business Combination from March 26, 2023 to March 26, 2024 and (iii) such earlier date as shall be determined by the Company’s board of directors and publicly announced by the Company. In connection with the shareholders’ vote at the Extraordinary Meeting, the holders of 25,790,900 public shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.20 per share, for an aggregate redemption amount of $263,071,273.79. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds are intended to be generally applied toward consummating a business combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting discount and taxes payable Upon the closing of the Initial Public Offering, management has agreed that an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including the proceeds of the Private Placement Warrants, will be held in the Trust Account and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account, except for the withdrawal of interest to pay the Company’s taxes and up to $100,000 to pay dissolution expenses, as applicable, if any, until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of the public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public Offering (as such period may be extended pursuant to a shareholder vote, the “ Combination Period The Company will provide its public shareholders with the opportunity to redeem all or a portion of their Class A Ordinary Shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two The Class A ordinary shares subject to redemption are recorded at a redemption value and were classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board’s (“ FASB ASC Following the Extension Vote, the Company has until March 26, 2024 (as the same may be further extended pursuant to a shareholder vote) to complete the initial Business Combination. However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor, officers and directors have agreed, pursuant to a letter agreement with the Company, to (i) waive their redemption rights with respect to their Founder Shares (as described in Note 6) and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its public shares if the Company has not consummated an initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and (iv) vote any Founder Shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than Marcum LLP, the Company’s independent auditor) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act Liquidity and Going Concern As of December 31, 2022, the Company had cash outside the Trust Account of $28,039 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business Combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of December 31, 2022, none of the amount in the Trust Account was available to be withdrawn as described above. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. On November 15, 2021, the Company issued an unsecured promissory note (the “Note”) in the amount of up to $250,000 to an affiliate of the Sponsor. The proceeds of the Note, which may be drawn down from time to time until the Company consummates its initial Business Combination, will be used for general working capital purposes. The Note bears no interest and is payable in full upon the earlier to occur of (i) twenty-four five If the Company’s estimates of the costs of undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amounts necessary to do so, the Company may have insufficient funds available to operate its business prior to the consummation of its Business Combination and may need to raise additional capital, e.g., through loans from its Sponsor, officers, directors or third parties. If the Company is unable to raise additional capital, it may be required to take additional measures to preserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company cannot assure you that its plans to raise capital or to consummate an initial Business Combination before March 26, 2024 (absent any further extensions of such period with shareholder approval) will be successful. In addition, the Company only has 24 months from the closing of the Initial Public Offering (as such period may be extended pursuant to a shareholder vote) to complete its initial Business Combination. If the Company has not completed its initial Business Combination within this Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten Management has determined that the Company could have insufficient liquidity to meet its anticipated obligations for at least twelve months after the financial statements are available to be issued due to recurring operating losses and negative cash utilized in operating activities. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors or third parties as needed. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. The Company cannot provide any assurance that new financing will be available to it on acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has also determined that the mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete its Initial Business Combination by March 26, 2023 (unless such a period is extended as described herein), then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 26, 2023. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and Russia-Ukraine war on the industry and has concluded that while it is reasonably possible that the virus and the Russia-Ukraine war could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Significant Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“ GAAP Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “ JOBS Act Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Marketable Securities Held in Trust Account At December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. Interest income is recognized when earned. The Company’s portfolio of marketable securities is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act. At December 31, 2022 and 2021, the Trust Account had $278,984,824 and $275,018,013 held in marketable securities, respectively. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2022 and 2021, the Company has not experienced losses on this account. Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A Ordinary Shares are subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, 27,500,000 Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. In connection with the shareholders’ vote at the Extraordinary Meeting, the holders of 25,790,900 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.20 per share, for an aggregate redemption amount of $263,071,273.79. As a result, there are currently 1,709,100 Class A ordinary shares outstanding. Net Income Per Ordinary Share The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 27,500,000 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the year ended December 31, 2022 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the year ended December 31, 2022 For the year ended December 31, 2021 Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income $ 10,860,193 $ 2,715,048 $ 3,622,927 $ 1,210,314 Denominator: Weighted-average shares outstanding 27,500,000 6,875,000 20,897,260 6,981,164 Basic and diluted net income per share $ 0.39 $ 0.39 $ 0.17 $ 0.17 Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“ SAB Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 14,166,667 ordinary share warrants issued in connection with the Initial Public Offering (8,333,333), Private Placement (4,666,667), and partial exercise of the Over-Allotment Option (1,166,667) as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the Initial Public Offering, Private Placement and partial exercise of the Over-Allotment Option has been estimated using Monte-Carlo simulations at each measurement date. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ ASC 740 ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ ASU 2020-06 Management does not believe that any other recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2022
Initial Public Offering [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share, par value $0.0001 per share and one-third In connection with the Initial Public Offering, the underwriters were granted a 45-day option from the date of the prospectus to purchase up to 3,750,000 additional units to cover over-allotments, if any. On May 5, 2021, the underwriters purchased an additional 2,500,000 Option Units pursuant to the partial exercise of the Over-Allotment Option. The Option Units were sold at an offering price of $10.00 per Unit, generating additional gross proceeds to the Company of $25,000,000. The aggregate number of Units outstanding as a result of the Initial Public Offering and the partial exercise of the Over-Allotment Option is 27,500,000 and the aggregate gross proceeds are $275,000,000. All of the 27,500,000 Class A ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary share subject to redemption to be classified outside of permanent equity. The Class A ordinary shares are subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable ordinary share resulted in charges against additional paid-in capital and accumulated deficit. As of December 31, 2022 and 2021, the ordinary share reflected on the balance sheet are reconciled in the following table: Gross proceeds from IPO $ 275,000,000 Less: Proceeds allocated to Public Warrants (12,161,523 ) Ordinary share issuance costs (14,578,504 ) Plus: Remeasurement of adjusted value of Class A Ordinary Shares to redemption value 26,740,027 Contingently redeemable ordinary shares at December 31, 2021 $ 275,000,000 Plus: Remeasurement of adjusted value of Class A Ordinary Shares to redemption value 3,984,823 Contingently redeemable ordinary shares at December 31, 2022 $ 278,984,823

Private Placement Warrants

Private Placement Warrants	12 Months Ended
	Dec. 31, 2022
Private Placement Warrants [Abstract]
Private Placement Warrants	Note 4 — Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 4,666,667 Private Placement Warrants at a price of $1.50 per warrant ($7,000,000 in the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A Ordinary Shares at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account. Also in connection with the partial exercise of the Over-Allotment Option, the Sponsor purchased an additional 333,333 Private Placement Warrants at a purchase price of $1.50 per Warrant. The aggregate number of Private Placement Warrants outstanding as a result of the Initial Public Offering and over-allotment is 5,000,000 and the aggregate proceeds are $7,500,000. The Private Placement Warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the Private Placement Warrants on a cashless basis. If the Private Placement Warrants are held by holders other than initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the Initial Public Offering. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the Initial Public Offering.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On December 30, 2020, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 shares of Class B Ordinary Shares, par value $0.0001 (the “ Founder Shares The initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class A Ordinary Shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “ Lock-Up Promissory Notes — Related Party On December 30, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. These loans are non-interest bearing, unsecured and are due at the earlier of September 30, 2021 or the closing of the Initial Public Offering. The loan was repaid upon the closing of the Initial Public Offering out of the offering proceeds that had been allocated to the payment of offering expenses. On November 15, 2021, the Company issued an unsecured promissory note in the amount of up to $250,000 to DTA Master, LLC, a Delaware limited-liability company, a related party and an affiliate of the Sponsor. The proceeds of the Note, which may be drawn down from time to time until the Company consummates its initial Business Combination, will be used for general working capital purposes. The Note bears no interest and is payable in full upon the earlier to occur of (i) twenty-four (24) months from the closing of the Initial Public Offering (or such later date as may be extended in accordance with the terms of the Company’s amended and restated memorandum and articles of association) or (ii) the consummation of the initial Business Combination. A failure to pay the principal within five Working Capital Loans In addition, in order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “ Working Capital Loans Administrative Support Agreement Commencing on the date of the Prospectus, the Company began to be obligated to pay the Sponsor up to $15,000 per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the year ended December 31, 2022, the Company incurred and accrued $176,243 of administrative support services fees, and for the year ended December 31, 2021, the Company incurred and accrued $131,634 of administrative support services fees.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 6 — Commitments and Contingencies Registration Rights The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the offering, (ii) Private Placement Warrants, which were issued in a private placement simultaneously with the closing of the offering and the Class A Ordinary Shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of working capital loans will have registration rights to require the Company to register a sale of any of the Company’s securities held by them pursuant to a registration rights agreement. Pursuant to the registration rights agreement and including the underwriters’ exercise of 2,500,000 units of their Over-Allotment Option and $1,500,000 of working capital loans are converted into Private Placement Warrants, the Company will be obligated to register up to 15,166,667 Class A Ordinary Shares and 6,000,000 warrants. The number of Class A Ordinary Shares includes (i) 6,875,000 Class A Ordinary Shares to be issued upon conversion of the Founder Shares, (ii) 5,000,000 Class A Ordinary Shares underlying the Private Placement Warrants and (iii) 1,000,000 Class A Ordinary Shares underlying the Private Placement Warrants issued upon conversion of working capital loans. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the Prospectus to purchase up to an additional 3,750,000 Units to cover over-allotments, if any. On May 5, 2021, the underwriters partially exercised the Over-Allotment Option to purchase an additional 2,500,000 units and forfeited the remainder. The underwriters were entitled to a cash underwriting discount of two percent (2%) of the gross proceeds of the Initial Public Offering and exercise of the Over-Allotment Option, or $5,500,000. Additionally, the underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the Initial Public Offering and the partial exercise of the Over-Allotment Option upon the completion of the Company’s initial Business Combination, or an aggregate of $9,625,000. Legal Fees The Company has engaged a law firm to provide legal due diligence services and business combination services related to potential business combination target companies. The Company currently expects that all fees and expenses related to the various engagements will be deferred and are to be paid fully upon the closing of its initial Business Combination. Deferred legal fees of $1,147,553 and $927,413 have been recorded and presented within accrued expenses within the accompanying balance sheets as of December 31, 2022 and 2021, respectively.

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
	Dec. 31, 2022
Shareholders' Deficit [Abstract]
Shareholders' Deficit	Note 7 — Shareholders’ Deficit Preference shares — The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. At December 31, 2022 and 2021, there were no preference shares issued or outstanding. Class A Ordinary Shares — The Company is authorized to issue a total of 200,000,000 Class A Ordinary Shares at par value of $0.0001 each. At December 31, 2022 and 2021, there were 27,500,000 shares of Class A Ordinary Shares outstanding, all of which are subject to possible redemption. Class B Ordinary Shares — The Company is authorized to issue a total of 20,000,000 Class B Ordinary Shares at par value of $0.0001 each. At December 31, 2022 and 2021, there were 6,875,000 Class B Ordinary Shares issued or outstanding. Holders of Class A Ordinary Shares and holders of Class B Ordinary Shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders. The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by public shareholders), including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Warrants

Warrants	12 Months Ended
	Dec. 31, 2022
Warrants [Abstract]
Warrants	Note 8 — Warrants Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance (the “ Newly Issued Price Market Value The warrants will become exercisable 30 days after the completion of the Company’s initial Business Combination and will expire five years after the completion of its initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than fifteen sixtieth th Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the reported closing price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described in the Prospectus under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.10 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; • if, and only if, the Reference Value (as defined above under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described in the Prospectus under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”); and • if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described in the Prospectus under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”), the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder’s ability to cashless exercise its warrants) as the outstanding Public Warrants, as described above. If the Company calls the Warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise his, her or its Warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their Warrants on a “cashless basis,” the management will consider, among other factors, the Company’s cash position, the number of Warrants that are outstanding and the dilutive effect on the Company’s shareholders of issuing the maximum number of Class A Ordinary Shares issuable upon the exercise of the Company’s warrants. If the management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of Class A Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Ordinary Shares underlying the warrants, multiplied by the excess of the “fair market value” of the Company’s Class A Ordinary Shares over the exercise price of the warrants by (y) the fair market value. The “fair market value” will mean the average reported closing price of the Class A Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2022
Fair Value Measurements [Abstract]
Fair Value Measurements	Note 9 — Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy. The following tables present information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and 2021 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: December 31, Quoted Prices In Active Markets Significant Other Observable Significant Other Unobservable 2022 (Level 1) Inputs (Level 2) Inputs (Level 3) Description Assets: Cash held in trust account $ 278,984,824 $ 278,984,824 $ — $ — Liabilities: Public Warrants 110,000 110,000 — — Private Warrants 67,421 — — 67,421 Total $ 177,421 $ 110,000 $ — $ 67,421 December 31, Quoted Prices In Active Markets Significant Other Observable Significant Other Unobservable 2021 (Level 1) Inputs (Level 2) Inputs (Level 3) Description Assets: Cash held in trust account $ 275,018,013 $ 275,018,013 $ — $ — Total $ 275,018,013 $ 275,018,013 $ — $ — Liabilities: Public Warrants 7,332,417 7,332,417 — — Private Warrants 4,012,649 — — 4,012,649 Total $ 11,345,066 $ 7,332,417 $ — $ 4,012,649 The fair value of the Public Warrants at December 31, 2022 and 2021 was classified as Level 1 due to the use of an observable market quote in an active market. Taking into account the make-whole provision included in the warrant agreement between the Company and Disruptive Acquisition Sponsor I, LLC, dated March 26, 2021, the Private Warrants are classified as level 2. The aforementioned warrant liabilities are not subject to qualified hedge accounting. The following table provides quantitative information regarding fair value measurements of warrant liabilities: December 31, 2022 December 31, 2021 Share price $ 10.08 $ 9.80 Strike price $ 11.50 $ 11.50 Term (in years) 0.61 5.45 Volatility 7.8 % 15.50 % Risk-free rate 4.75 % 1.30 % Dividend yield 0.00 % 0.00 % The following table presents the changes in the fair value of warrant liabilities: Public Private Placement Redeemable (over-allotment) Private Placement (over-allotment) Warrant Liabilities Fair value as of December 31, 2021 $ 6,665,833 $ 3,745,139 $ 666,584 $ 267,510 $ 11,345,066 Change in valuation inputs or other assumptions (6,565,833 ) (3,682,213 ) (656,584 ) (263,015 ) (11,167,645 ) Fair value as of December 31, 2022 $ 100,000 $ 62,926 $ 10,000 $ 4,495 $ 177,421

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, other than as stated below. On February 14, 2023, the Company held an Extraordinary Meeting. At the Extraordinary Meeting, the Company’s shareholders approved, among other things, an amendment to the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate an initial business combination from March 26, 2023 to March 26, 2024 or such earlier date as shall be determined by the Company’s board of directors and publicly announced by the Company. In connection with the shareholders’ vote at the Extraordinary Meeting, the holders of 25,790,900 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.20 per share, for an aggregate redemption amount of $263,071,273.79. On April 17, 2023, the Company amended and restated the Note in its entirety to increase

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“ GAAP
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. Interest income is recognized when earned. The Company’s portfolio of marketable securities is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act. At December 31, 2022 and 2021, the Trust Account had $278,984,824 and $275,018,013 held in marketable securities, respectively. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2022 and 2021, the Company has not experienced losses on this account.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A Ordinary Shares are subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, 27,500,000 Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. In connection with the shareholders’ vote at the Extraordinary Meeting, the holders of 25,790,900 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.20 per share, for an aggregate redemption amount of $263,071,273.79. As a result, there are currently 1,709,100 Class A ordinary shares outstanding.
Net Income Per Ordinary Share	Net Income Per Ordinary Share The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 27,500,000 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the year ended December 31, 2022 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the year ended December 31, 2022 For the year ended December 31, 2021 Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income $ 10,860,193 $ 2,715,048 $ 3,622,927 $ 1,210,314 Denominator: Weighted-average shares outstanding 27,500,000 6,875,000 20,897,260 6,981,164 Basic and diluted net income per share $ 0.39 $ 0.39 $ 0.17 $ 0.17
Offering Costs	Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“ SAB
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 14,166,667 ordinary share warrants issued in connection with the Initial Public Offering (8,333,333), Private Placement (4,666,667), and partial exercise of the Over-Allotment Option (1,166,667) as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the Initial Public Offering, Private Placement and partial exercise of the Over-Allotment Option has been estimated using Monte-Carlo simulations at each measurement date.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ ASC 740 ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ ASU 2020-06 Management does not believe that any other recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Significant Accounting Policies [Abstract]
Net Income Per Ordinary Share	The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the year ended December 31, 2022 For the year ended December 31, 2021 Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income $ 10,860,193 $ 2,715,048 $ 3,622,927 $ 1,210,314 Denominator: Weighted-average shares outstanding 27,500,000 6,875,000 20,897,260 6,981,164 Basic and diluted net income per share $ 0.39 $ 0.39 $ 0.17 $ 0.17

Initial Public Offering (Tables

Initial Public Offering (Tables)	12 Months Ended
	Dec. 31, 2022
Initial Public Offering [Abstract]
Ordinary Shares Subject to Possible Redemption	As of December 31, 2022 and 2021, the ordinary share reflected on the balance sheet are reconciled in the following table: Gross proceeds from IPO $ 275,000,000 Less: Proceeds allocated to Public Warrants (12,161,523 ) Ordinary share issuance costs (14,578,504 ) Plus: Remeasurement of adjusted value of Class A Ordinary Shares to redemption value 26,740,027 Contingently redeemable ordinary shares at December 31, 2021 $ 275,000,000 Plus: Remeasurement of adjusted value of Class A Ordinary Shares to redemption value 3,984,823 Contingently redeemable ordinary shares at December 31, 2022 $ 278,984,823

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Measurements [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy. The following tables present information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and 2021 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: December 31, Quoted Prices In Active Markets Significant Other Observable Significant Other Unobservable 2022 (Level 1) Inputs (Level 2) Inputs (Level 3) Description Assets: Cash held in trust account $ 278,984,824 $ 278,984,824 $ — $ — Liabilities: Public Warrants 110,000 110,000 — — Private Warrants 67,421 — — 67,421 Total $ 177,421 $ 110,000 $ — $ 67,421 December 31, Quoted Prices In Active Markets Significant Other Observable Significant Other Unobservable 2021 (Level 1) Inputs (Level 2) Inputs (Level 3) Description Assets: Cash held in trust account $ 275,018,013 $ 275,018,013 $ — $ — Total $ 275,018,013 $ 275,018,013 $ — $ — Liabilities: Public Warrants 7,332,417 7,332,417 — — Private Warrants 4,012,649 — — 4,012,649 Total $ 11,345,066 $ 7,332,417 $ — $ 4,012,649
Level 3 Fair Value Measurement Inputs	The following table provides quantitative information regarding fair value measurements of warrant liabilities: December 31, 2022 December 31, 2021 Share price $ 10.08 $ 9.80 Strike price $ 11.50 $ 11.50 Term (in years) 0.61 5.45 Volatility 7.8 % 15.50 % Risk-free rate 4.75 % 1.30 % Dividend yield 0.00 % 0.00 %
Changes in Fair Value of Warrant Liabilities	The following table presents the changes in the fair value of warrant liabilities: Public Private Placement Redeemable (over-allotment) Private Placement (over-allotment) Warrant Liabilities Fair value as of December 31, 2021 $ 6,665,833 $ 3,745,139 $ 666,584 $ 267,510 $ 11,345,066 Change in valuation inputs or other assumptions (6,565,833 ) (3,682,213 ) (656,584 ) (263,015 ) (11,167,645 ) Fair value as of December 31, 2022 $ 100,000 $ 62,926 $ 10,000 $ 4,495 $ 177,421

Organization and Business Ope_2

Organization and Business Operations (Details)						12 Months Ended
	Feb. 14, 2023 USD ($) $ / shares shares	Nov. 15, 2021 USD ($)	May 06, 2021 USD ($)	May 05, 2021 USD ($) $ / shares shares	Mar. 26, 2021 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) Business $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Apr. 17, 2023 USD ($)	Aug. 18, 2022 USD ($)	Apr. 12, 2022 USD ($)	Mar. 03, 2021 USD ($)
Organization and Business Operations [Abstract]
Number of shares issued upon exercise of warrant (in shares) | shares						1
Term of option for underwriters to purchase additional Units to cover over-allotments						45 days
Exercise price of warrant (in dollars per share) | $ / shares						$ 11.5
Gross proceeds from equity issuance, initial public offering			$ 275,000,000		$ 250,000,000
Net proceeds from initial public offering						$ 0	$ 245,000,000
Warrants issued (in shares) | shares					14,166,667
Gross proceeds from private placement						0	7,000,000
Net proceeds from Initial Public Offering and Private Placement deposited in trust account						$ 0	275,000,000
Period to complete Business Combination from closing of Initial Public Offering						24 months
Interest on Trust Account to be held to pay dissolution expenses						$ 100,000
Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period						100%
Period to redeem shares at per-share price, payable in cash, equal to aggregate amount then on deposit in the Trust Account						2 days
Net Tangible Asset Threshold for Redeeming Public Shares						$ 5,000,001
Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period						10 days
Cash						$ 28,039	213,495
Borrowings outstanding						$ 750,000	77,000
Minimum [Member]
Organization and Business Operations [Abstract]
Number of operating businesses included in initial Business Combination | Business						1
Fair market value as percentage of net assets held in Trust Account included in initial Business Combination						80%
Post-transaction ownership percentage of the target business						50%
Maximum [Member]
Organization and Business Operations [Abstract]
Interest on Trust Account to be held to pay dissolution expenses											$ 100,000
Promissory Note [Member]
Organization and Business Operations [Abstract]
Borrowings outstanding						$ 750,000	$ 77,000
Principal amount									$ 750,000	$ 500,000
Promissory Note [Member] | Subsequent Event [Member]
Organization and Business Operations [Abstract]
Principal amount								$ 1,500,000
DTA Master, LLC [Member] | Promissory Note [Member]
Organization and Business Operations [Abstract]
Related party transaction amount		$ 250,000
Period to pay Note payable in full		24 months
Number of business days to pay principal amount		5 days
Public Warrants [Member]
Organization and Business Operations [Abstract]
Warrants issued (in shares) | shares					8,333,333
Private Placement Warrants [Member]
Organization and Business Operations [Abstract]
Warrants issued (in shares) | shares				333,333	4,666,667
Class A Ordinary Shares [Member]
Organization and Business Operations [Abstract]
Ordinary shares, par value (in dollars per share) | $ / shares						$ 0.0001	$ 0.0001
Class A Ordinary Shares [Member] | Subsequent Event [Member]
Organization and Business Operations [Abstract]
Number of shares exercised from right to redeem for cash (in shares) | shares	25,790,900
Redemption price (in dollars per share) | $ / shares	$ 10.2
Aggregate redemption amount	$ 263,071,273.79
Option Units [Member]
Organization and Business Operations [Abstract]
Net proceeds from initial public offering			$ 25,000,000
Public Shares [Member] | Subsequent Event [Member]
Organization and Business Operations [Abstract]
Number of shares exercised from right to redeem for cash (in shares) | shares	25,790,900
Redemption price (in dollars per share) | $ / shares	$ 10.2
Aggregate redemption amount	$ 263,071,273.79
Initial Public Offering [Member]
Organization and Business Operations [Abstract]
Units issued (in shares) | shares					25,000,000
Share price (in dollars per share) | $ / shares					$ 10
Net proceeds from initial public offering							$ 275,000,000
Net proceeds from Initial Public Offering and Private Placement deposited in trust account					$ 250,000,000
Redemption price (in dollars per share) | $ / shares					$ 10
Cash deposited in Trust Account per Unit (in dollars per share) | $ / shares						$ 10
Initial Public Offering [Member] | Public Warrants [Member]
Organization and Business Operations [Abstract]
Number of securities included in each Unit (in shares) | shares					0.33
Exercise price of warrant (in dollars per share) | $ / shares					$ 11.5
Initial Public Offering [Member] | Class A Ordinary Shares [Member]
Organization and Business Operations [Abstract]
Number of securities included in each Unit (in shares) | shares					1
Number of shares issued upon exercise of warrant (in shares) | shares					1
Ordinary shares, par value (in dollars per share) | $ / shares					$ 0.0001
Over-Allotment Option [Member]
Organization and Business Operations [Abstract]
Units issued (in shares) | shares				2,500,000
Term of option for underwriters to purchase additional Units to cover over-allotments						45 days
Share price (in dollars per share) | $ / shares				$ 10
Gross proceeds from equity issuance, initial public offering				$ 25,000,000		$ 275,000,000
Net proceeds from initial public offering				$ 25,000,000
Warrants issued (in shares) | shares					1,166,667
Over-Allotment Option [Member] | Minimum [Member]
Organization and Business Operations [Abstract]
Related party transaction amount						$ 1,500,000
Over-Allotment Option [Member] | Maximum [Member]
Organization and Business Operations [Abstract]
Additional Units that can be purchased to cover over-allotments (in shares) | shares					3,750,000	3,750,000
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares					$ 1.5
Warrants issued (in shares) | shares					333,333
Private Placement [Member]
Organization and Business Operations [Abstract]
Gross proceeds from private placement					$ 7,000,000
Private Placement [Member] | Private Placement Warrants [Member]
Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares				$ 1.5	$ 1.5
Warrants issued (in shares) | shares					4,666,667
Gross proceeds from private placement				$ 500,000
Private Placement [Member] | Class A Ordinary Shares [Member] | Private Placement Warrants [Member]
Organization and Business Operations [Abstract]
Number of shares issued upon exercise of warrant (in shares) | shares					1
Exercise price of warrant (in dollars per share) | $ / shares					$ 11.5

Significant Accounting Polici_4

Significant Accounting Policies, Marketable Securities Held in Trust Account (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Cash Held in Trust Account [Abstract]
Marketable securities held in trust account	$ 278,984,824	$ 275,018,013

Significant Accounting Polici_5

Significant Accounting Policies, Ordinary Shares Subject to Possible Redemption (Details) - USD ($)	Feb. 14, 2023	Dec. 31, 2022	Dec. 31, 2021
Ordinary Shares Subject to Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)		27,500,000	27,500,000
Class A Ordinary Shares [Member]
Ordinary Shares Subject to Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)		27,500,000	27,500,000
Shares outstanding (in shares)		0	0
Class A Ordinary Shares [Member] | Subsequent Event [Member]
Ordinary Shares Subject to Possible Redemption [Abstract]
Number of shares exercised from right to redeem for cash (in shares)	25,790,900
Redemption price (in dollars per share)	$ 10.2
Aggregate redemption amount	$ 263,071,273.79
Shares outstanding (in shares)	1,709,100

Significant Accounting Polici_6

Significant Accounting Policies, Net Income Per Ordinary Share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net Income Per Ordinary Share [Abstract]
Antidilutive shares excluded from computation (in shares)	27,500,000
Class A [Member]
Numerator [Abstract]
Allocation of net income	$ 10,860,193	$ 3,622,927
Denominator [Abstract]
Basic weighted average shares outstanding (in shares)	27,500,000	20,897,260
Diluted weighted average shares outstanding (in shares)	27,500,000	20,897,260
Basic net income per share (in dollars per share)	$ 0.39	$ 0.17
Diluted net income per share (in dollars per share)	$ 0.39	$ 0.17
Class B [Member]
Numerator [Abstract]
Allocation of net income	$ 2,715,048	$ 1,210,314
Denominator [Abstract]
Basic weighted average shares outstanding (in shares)	6,875,000	6,981,164
Diluted weighted average shares outstanding (in shares)	6,875,000	6,981,164
Basic net income per share (in dollars per share)	$ 0.39	$ 0.17
Diluted net income per share (in dollars per share)	$ 0.39	$ 0.17

Significant Accounting Polici_7

Significant Accounting Policies, Offering Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Offering Costs [Abstract]
Offering costs	$ 15,759,367
Underwriting discount	5,500,000
Deferred underwriting discount	9,625,000	$ 9,625,000
Other offering costs	$ 634,367

Significant Accounting Polici_8

Significant Accounting Policies, Derivative Warrant Liabilities (Details) - shares	May 05, 2021	Mar. 26, 2021
Derivative Warrant Liabilities [Abstract]
Warrants issued (in shares)		14,166,667
Over-Allotment Option [Member]
Derivative Warrant Liabilities [Abstract]
Warrants issued (in shares)		1,166,667
Public Warrants [Member]
Derivative Warrant Liabilities [Abstract]
Warrants issued (in shares)		8,333,333
Private Warrants [Member]
Derivative Warrant Liabilities [Abstract]
Warrants issued (in shares)	333,333	4,666,667
Private Warrants [Member] | Over-Allotment Option [Member]
Derivative Warrant Liabilities [Abstract]
Warrants issued (in shares)		333,333

Significant Accounting Polici_9

Significant Accounting Policies, Income Taxes (Details)	Dec. 31, 2022 USD ($)
Income Taxes [Abstract]
Unrecognized tax benefits	$ 0
Accrued interest and penalties	$ 0

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)				12 Months Ended
	May 06, 2021	May 05, 2021	Mar. 26, 2021	Dec. 31, 2022	Dec. 31, 2021
Initial Public Offering [Abstract]
Number of shares issued upon exercise of warrant (in shares)				1
Exercise price of warrant (in dollars per share)				$ 11.5
Term of option for underwriters to purchase additional Units to cover over-allotments				45 days
Gross Proceeds from Issuance, Initial Public Offering	$ 275,000,000		$ 250,000,000
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Ordinary shares, redemption (in shares)				27,500,000	27,500,000
Gross proceeds from IPO				$ 0	$ 245,000,000
Ordinary shares issuance costs				0	(575,716)
Contingently redeemable ordinary shares				275,000,000
Contingently redeemable ordinary shares				$ 278,984,823	$ 275,000,000
Class A Ordinary Shares [Member]
Initial Public Offering [Abstract]
Ordinary shares, par value (in dollars per share)				$ 0.0001	$ 0.0001
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Ordinary shares, redemption (in shares)				27,500,000	27,500,000
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Units issued (in shares)			25,000,000
Share price (in dollars per share)			$ 10
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Gross proceeds from IPO					$ 275,000,000
Initial Public Offering [Member] | Public Warrants [Member]
Initial Public Offering [Abstract]
Number of securities included in each Unit (in shares)			0.33
Exercise price of warrant (in dollars per share)			$ 11.5
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Less: Proceeds allocated to Public Warrants					(12,161,523)
Initial Public Offering [Member] | Class A Ordinary Shares [Member]
Initial Public Offering [Abstract]
Number of securities included in each Unit (in shares)			1
Ordinary shares, par value (in dollars per share)			$ 0.0001
Number of shares issued upon exercise of warrant (in shares)			1
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Ordinary shares issuance costs					(14,578,504)
Contingently redeemable ordinary shares				$ 275,000,000
Remeasurement of adjusted value of Class A Ordinary Shares to redemption value				3,984,823	26,740,027
Contingently redeemable ordinary shares				$ 278,984,823	$ 275,000,000
Over-Allotment Option [Member]
Initial Public Offering [Abstract]
Units issued (in shares)		2,500,000
Share price (in dollars per share)		$ 10
Term of option for underwriters to purchase additional Units to cover over-allotments				45 days
Gross Proceeds from Issuance, Initial Public Offering		$ 25,000,000		$ 275,000,000
Units Outstanding (in shares)				27,500,000
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Gross proceeds from IPO		$ 25,000,000
Over-Allotment Option [Member] | Maximum [Member]
Initial Public Offering [Abstract]
Additional Units that can be purchased to cover over-allotments (in shares)			3,750,000	3,750,000

Private Placement Warrants (Det

Private Placement Warrants (Details) - USD ($)	May 05, 2021	Mar. 26, 2021	Dec. 31, 2022
Private Placement [Abstract]
Warrants issued (in shares)		14,166,667
Number of ordinary share called by each warrant (in shares)			1
Exercise price of warrant (in dollars per share)			$ 11.5
Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)	333,333	4,666,667
Private Placement [Member] | Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)		4,666,667
Share price (in dollars per share)	$ 1.5	$ 1.5
Proceeds from private placement of warrants		$ 7,000,000
Private Placement [Member] | Private Placement Warrants [Member] | Class A Ordinary Shares [Member]
Private Placement [Abstract]
Number of ordinary share called by each warrant (in shares)		1
Exercise price of warrant (in dollars per share)		$ 11.5
Over-Allotment Option [Member]
Private Placement [Abstract]
Warrants issued (in shares)		1,166,667
Share price (in dollars per share)	$ 10
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)		333,333
Share price (in dollars per share)		$ 1.5
IPO [Member]
Private Placement [Abstract]
Share price (in dollars per share)		$ 10
IPO [Member] | Class A Ordinary Shares [Member]
Private Placement [Abstract]
Number of ordinary share called by each warrant (in shares)		1
IPO [Member] | Private Placement Warrants [Member]
Private Placement [Abstract]
Proceeds from private placement of warrants		$ 7,500,000
Warrants outstanding (in shares)		5,000,000

Related Party Transactions, Fou

Related Party Transactions, Founder Shares (Details) - USD ($)			12 Months Ended
	Mar. 08, 2021	Dec. 30, 2020	Dec. 31, 2022	Dec. 31, 2021	May 05, 2021
Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)			$ 0.0001	$ 0.0001
Shares outstanding (in shares)			0	0
Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)			$ 0.0001	$ 0.0001
Shares outstanding (in shares)			6,875,000	6,875,000
Sponsor [Member] | Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Proceeds from issuance of common stock		$ 25,000
Share price (in dollars per share)		$ 0.003
Issuance of Class B ordinary shares to Sponsor (in shares)		7,187,500
Founder Shares [Member] | Sponsor [Member] | Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Threshold trading days			20 days
Threshold consecutive trading days			30 days
Founder Shares [Member] | Sponsor [Member] | Class A Ordinary Shares [Member] | Minimum [Member]
Founder Shares [Abstract]
Share price (in dollars per share)			$ 12
Threshold period after initial Business Combination			150 days
Founder Shares [Member] | Sponsor [Member] | Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)		$ 0.0001
Number of shares no longer subject to forfeiture (in shares)					625,000
Shares outstanding (in shares)					6,875,000
Number of shares transferred to directors (in shares)	135,000
Holding period for transfer, assignment or sale of Founder Shares			1 year
Founder Shares [Member] | Sponsor [Member] | Class B Ordinary Shares [Member] | Maximum [Member]
Founder Shares [Abstract]
Shares subject to forfeiture (in shares)		937,500

Related Party Transactions, Pro

Related Party Transactions, Promissory Notes - Related Party (Details) - USD ($)	Nov. 15, 2021	Dec. 30, 2020	Apr. 17, 2023	Dec. 31, 2022	Aug. 18, 2022	Apr. 12, 2022	Dec. 31, 2021
Related Party Loans [Abstract]
Borrowings outstanding				$ 750,000			$ 77,000
Promissory Note [Member]
Related Party Loans [Abstract]
Borrowings outstanding				$ 750,000			$ 77,000
Principal amount					$ 750,000	$ 500,000
Promissory Note [Member] | Subsequent Event [Member]
Related Party Loans [Abstract]
Principal amount			$ 1,500,000
Sponsor [Member]
Related Party Loans [Abstract]
Related party transaction amount		$ 300,000
DTA Master, LLC [Member] | Promissory Note [Member]
Related Party Loans [Abstract]
Related party transaction amount	$ 250,000
Period to pay Note payable in full	24 months
Number of business days to pay principal amount	5 days

Related Party Transactions, Wor

Related Party Transactions, Working Capital Loans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Borrowings outstanding	$ 750,000	$ 77,000
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | Working Capital Loans [Member]
Related Party Transactions [Abstract]
Borrowings outstanding	0	$ 0
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | Working Capital Loans [Member] | Maximum [Member]
Related Party Transactions [Abstract]
Amount of related party transaction	$ 1,500,000
Share price (in dollars per share)	$ 1.5

Related Party Transactions, Adm

Related Party Transactions, Administrative Support Agreement (Details) - USD ($)			12 Months Ended
	Mar. 26, 2021	Dec. 30, 2020	Dec. 31, 2022	Dec. 31, 2021
Administrative Support Agreement [Member]
Related Party Transactions [Abstract]
Due to related party			$ 176,243	$ 131,634
Sponsor [Member]
Related Party Transactions [Abstract]
Monthly related party fee		$ 300,000
Sponsor [Member] | Administrative Support Agreement [Member] | Maximum [Member]
Related Party Transactions [Abstract]
Monthly related party fee	$ 15,000

Commitments and Contingencies (

Commitments and Contingencies (Details)			12 Months Ended
	May 05, 2021 shares	Mar. 26, 2021 USD ($) shares	Dec. 31, 2022 USD ($) Individual shares	Dec. 31, 2021 USD ($)
Registration Rights [Abstract]
Warrants to be registered pursuant to registration rights agreement (in shares)			6,000,000
Underwriting Agreement [Abstract]
Term of option for underwriters to purchase additional Units to cover over-allotments			45 days
Cash underwriting discount percentage		2%
Underwriting discount | $			$ 5,500,000
Underwriter deferred fee discount		3.50%
Legal Fees [Abstract]
Deferred legal fees | $			$ 1,147,553	$ 927,413
Class A Ordinary Shares [Member]
Registration Rights [Abstract]
Ordinary shares to be registered pursuant to registration rights agreement (in shares)			6,875,000
Class A Ordinary Shares [Member] | Working Capital Loans [Member]
Registration Rights [Abstract]
Ordinary shares to be registered pursuant to registration rights agreement (in shares)			1,000,000
Class A Ordinary Shares [Member] | Private Placement Warrants [Member]
Registration Rights [Abstract]
Ordinary shares to be registered pursuant to registration rights agreement (in shares)			5,000,000
Maximum [Member]
Registration Rights [Abstract]
Number of demands eligible security holder can make | Individual			3
Minimum [Member]
Registration Rights [Abstract]
Ordinary shares to be registered pursuant to registration rights agreement (in shares)			15,166,667
Initial Public Offering [Member]
Registration Rights [Abstract]
Units issued (in shares)		25,000,000
Underwriting Agreement [Abstract]
Underwriting discount | $		$ 5,500,000
Over-Allotment Option [Member]
Registration Rights [Abstract]
Units issued (in shares)	2,500,000
Underwriting Agreement [Abstract]
Term of option for underwriters to purchase additional Units to cover over-allotments			45 days
Over-Allotment Option [Member] | Maximum [Member]
Underwriting Agreement [Abstract]
Additional Units that can be purchased to cover over-allotments (in shares)		3,750,000	3,750,000
Underwriting discount | $		$ 9,625,000
Over-Allotment Option [Member] | Minimum [Member]
Registration Rights [Abstract]
Amount of related party transaction | $			$ 1,500,000

Shareholders' Deficit (Details)

Shareholders' Deficit (Details)	12 Months Ended
	Dec. 31, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares
Stockholders' Deficit [Abstract]
Preference shares, shares authorized (in shares)	1,000,000
Preference shares, par value (in dollars per share) | $ / shares	$ 0.0001
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Ordinary shares subject to possible redemption (in shares)	27,500,000	27,500,000
Number of votes per share | Vote	1
Stock conversion percentage threshold	20%
Stock conversion basis of Class B to Class A common stock at time of initial Business Combination	1
Class A Ordinary Shares [Member]
Stockholders' Deficit [Abstract]
Ordinary shares, shares authorized (in shares)	200,000,000	200,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)	0	0
Ordinary shares, shares outstanding (in shares)	0	0
Ordinary shares subject to possible redemption (in shares)	27,500,000	27,500,000
Class B Ordinary Shares [Member]
Stockholders' Deficit [Abstract]
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)	6,875,000	6,875,000
Ordinary shares, shares outstanding (in shares)	6,875,000	6,875,000

Warrants (Details)

Warrants (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Warrants [Abstract]
Number of shares issued upon exercise of warrant (in shares) | shares	1
Exercise price of warrant (in dollars per share)	$ 11.5
Trading day period to calculate volume weighted average trading price	10 days
Warrant redemption price (in dollars per share)	$ 0.01
Period to exercise warrants after business combination	30 days
Expiration period of warrants	5 years
Period to file registration statement after initial Business Combination	15 days
Period for registration statement to become effective	60 days
Trading day period to calculate volume weighted average trading price	10 days
Redemption period.	3 days
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member]
Warrants [Abstract]
Warrant redemption price (in dollars per share)	$ 0.01
Notice period to redeem warrants	30 days
Threshold trading days	20 days
Threshold Consecutive Trading Days	30 days
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Class A Ordinary Shares [Member] | Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 18
Redemption of Warrants When Price Equals or Exceeds $10.00 [Member]
Warrants [Abstract]
Warrant redemption price (in dollars per share)	$ 0.1
Notice period to redeem warrants	30 days
Redemption of Warrants When Price Equals or Exceeds $10.00 [Member] | Class A Ordinary Shares [Member] | Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 10
Additional Issue of Common Stock or Equity-Linked Securities [Member]
Warrants [Abstract]
Warrant redemption price (in dollars per share)	$ 18
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Minimum [Member]
Warrants [Abstract]
Percentage Multiplier	115%
Aggregate gross proceeds from issuance as a percentage of total equity proceeds	60%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Maximum [Member]
Warrants [Abstract]
Percentage Multiplier	180%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Class A Ordinary Shares [Member] | Maximum [Member]
Warrants [Abstract]
Share price (in dollars per share)	$ 9.2

Fair Value Measurements, Assets

Fair Value Measurements, Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Liabilities [Abstract]
Warrant liabilities	$ 177,421	$ 11,345,066
Recurring [Member]
Assets [Abstract]
Cash held in trust account	278,984,824	275,018,013
Total	278,984,824	275,018,013
Liabilities [Abstract]
Total	177,421	11,345,066
Recurring [Member] | Public Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	110,000	7,332,417
Recurring [Member] | Private Placement Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	67,421	4,012,649
Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]
Assets [Abstract]
Cash held in trust account	278,984,824	275,018,013
Total	278,984,824	275,018,013
Liabilities [Abstract]
Total	110,000	7,332,417
Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Public Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	110,000	7,332,417
Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Private Placement Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	0	0
Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]
Assets [Abstract]
Cash held in trust account	0	0
Total	0	0
Liabilities [Abstract]
Total	0	0
Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | Public Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	0	0
Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | Private Placement Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	0	0
Recurring [Member] | Significant Other Unobservable Inputs (Level 3) [Member]
Assets [Abstract]
Cash held in trust account	0	0
Total	0	0
Liabilities [Abstract]
Total	67,421	4,012,649
Recurring [Member] | Significant Other Unobservable Inputs (Level 3) [Member] | Public Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	0	0
Recurring [Member] | Significant Other Unobservable Inputs (Level 3) [Member] | Private Placement Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	$ 67,421	$ 4,012,649

Fair Value Measurements, Level

Fair Value Measurements, Level 3 Fair Value Measurement Inputs (Details)	Dec. 31, 2022 $ / shares	Dec. 31, 2021 $ / shares
Fair Value Measurements [Abstract]
Term (in years)	5 years
Warrants [Member]
Fair Value Measurements [Abstract]
Term (in years)	7 months 9 days	5 years 5 months 12 days
Warrants [Member] | Share Price [Member]
Fair Value Measurements [Abstract]
Measurement input	10.08	9.8
Warrants [Member] | Strike Price [Member]
Fair Value Measurements [Abstract]
Measurement input	11.5	11.5
Warrants [Member] | Volatility [Member]
Fair Value Measurements [Abstract]
Measurement input	0.078	0.155
Warrants [Member] | Risk Free Rate [Member]
Fair Value Measurements [Abstract]
Measurement input	0.0475	0.013
Warrants [Member] | Dividend Yield [Member]
Fair Value Measurements [Abstract]
Measurement input	0	0

Fair Value Measurements, Change

Fair Value Measurements, Change in Fair Value of Warrant Liabilities (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Changes in Fair Value of Warrant Liabilities [Roll Forward]
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net
Public Warrants [Member] | Initial Public Offering [Member]
Changes in Fair Value of Warrant Liabilities [Roll Forward]
Fair value	$ 6,665,833
Change in valuation inputs or other assumptions	(6,565,833)
Fair value	100,000
Public Warrants [Member] | Over-Allotment Option [Member]
Changes in Fair Value of Warrant Liabilities [Roll Forward]
Fair value	666,584
Change in valuation inputs or other assumptions	(656,584)
Fair value	10,000
Private Placement Warrants [Member] | Private Placement [Member]
Changes in Fair Value of Warrant Liabilities [Roll Forward]
Fair value	3,745,139
Change in valuation inputs or other assumptions	(3,682,213)
Fair value	62,926
Private Placement Warrants [Member] | Over-Allotment Option [Member]
Changes in Fair Value of Warrant Liabilities [Roll Forward]
Fair value	267,510
Change in valuation inputs or other assumptions	(263,015)
Fair value	4,495
Warrant Liabilities [Member]
Changes in Fair Value of Warrant Liabilities [Roll Forward]
Fair value	11,345,066
Change in valuation inputs or other assumptions	(11,167,645)
Fair value	$ 177,421

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Feb. 14, 2023	Apr. 17, 2023	Aug. 18, 2022	Apr. 12, 2022
Promissory Note [Member]
Subsequent Events [Abstract]
Principal amount			$ 750,000	$ 500,000
Promissory Note [Member] | Subsequent Event [Member]
Subsequent Events [Abstract]
Principal amount		$ 1,500,000
Class A Ordinary Shares [Member] | Subsequent Event [Member]
Subsequent Events [Abstract]
Number of shares exercised from right to redeem for cash (in shares)	25,790,900
Redemption price (in dollars per share)	$ 10.2
Aggregate redemption amount	$ 263,071,273.79